Publications by authors named "Thomas A Schmidt"

Claim this Profile
M
Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitus.
Heinz Drexel, Andreas Festa, Thomas A Schmidt, Bianca Rocca, Dobromir Dobrev

Eur Heart J Cardiovasc Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming health care: Investigating Influenzer, a novel telemedicine-supported early discharge program for patients with lower respiratory tract infection: A non-randomized feasibility study.
Tatjana Sandreva, Maria N Larsen, Maja K Rasmussen, Thyge L Nielsen, Charlotte von Sydow, Thomas A Schmidt

J Telemed Telecare· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The healthcare professional's encounter with the seriously ill and dying patient in the hospital].
Laura Bogut, Kristoffer Marså, Thomas A Schmidt, Anna Gade Holdensen, Mette Neergaard

Ugeskr Laeger· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sepsis research is hampered by the lack of a clear definition of suspected infection.
Lana Chafranska, Rune Husås Sørensen, Osama Bin Abdullah, Thomas Andersen Schmidt, Finn Erland Nielsen

Dan Med J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of rehabilitation and palliation for people with severe lung disease or heart failure - a scoping review.
Kristoffer Marsaa, Stig Molsted, Christian Have Dall, Henrik Hansen, Lise Nottelmann, Thomas A Schmidt

Eur Clin Respir J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-Year Mortality and Prognostic Factors in Sepsis: A Prospective Cohort Study of 714 Danish Emergency Department Patients.
Finn Erland Nielsen, Lana Chafranska, Rune H Sørensen, Thomas Andersen Schmidt, Osama Bin Abdullah

Clin Epidemiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abated crowding by fast-tracking the Throughput component of the ED for patients in no need of hospitalization with competency managed personnel.
Jesper Juul Larsen, Halfdan Lauridsen, Laurits Wullum Gundersen, Birgit Falk Riecke, Thomas A Schmidt

BMC Emerg Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Early Warning Score and New-Onset Atrial Fibrillation for Predicting In-Hospital Mortality or Transfer to the Intensive Care Unit in Emergency Department Patients with Suspected Bacterial Infections.
Finn Erland Nielsen, Christina Seefeldt Stæhr, Rune Husås Sørensen, Thomas Andersen Schmidt, S M Osama Bin Abdullah

Infect Drug Resist· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy.
Heinz Drexel, Stuart J Pocock, Basil S Lewis, Christoph H Saely, Juan Carlos Kaski, Thomas A Schmidt

Eur Heart J Cardiovasc Pharmacother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Maria Lukács Krogager, Kristian Kragholm, Jesper Qvist Thomassen, Peter Søgaard, Basil S Lewis, Thomas Andersen Schmidt

Eur Heart J Cardiovasc Pharmacother· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials.
Heinz Drexel, Basil S Lewis, Giuseppe M C Rosano, Christoph H Saely, Gerda Tautermann, Thomas A Schmidt

Eur Heart J Cardiovasc Pharmacother· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.
Gianluigi Savarese, Martin F Reiner, Alicia Uijl, Domenico D'Amario, Stefan Agewall, Thomas A Schmidt

Eur Heart J Cardiovasc Pharmacother· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.
Patrick Sulzgruber, Sven Wassmann, Anne Grete Semb, Wolfram Doehner, Petr Widimsky, Thomas Andersen Schmidt

Eur Heart J· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.
Patrick Sulzgruber, Sven Wassmann, Anne Grete Semb, Wolfram Doehner, Petr Widimsky, Thomas Andersen Schmidt

Eur Heart J Cardiovasc Pharmacother· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potassium homoeostasis and pathophysiology of hyperkalaemia.
Keld Per Kjeldsen, Thomas Andersen Schmidt

Eur Heart J Suppl· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-stay unit hospitalisation vs. standard care outcomes in older internal medicine patients-a randomised clinical trial.
Camilla Strøm, Lars Simon Rasmussen, Anne-Sophie Löwe, Anne Kathrine Lorentzen, Nicolai Lohse, Thomas Andersen Schmidt

Age Ageing· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.
Alexander Vonbank, Heinz Drexel, Stefan Agewall, Basil S Lewis, Joern F Dopheide, Thomas Andersen Schmidt

Eur Heart J Cardiovasc Pharmacother· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalisation in short-stay units for adults with internal medicine diseases and conditions.
Camilla Strøm, Jakob S Stefansson, Maria Louise Fabritius, Lars S Rasmussen, Thomas A Schmidt

Cochrane Database Syst Rev· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Giuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, Mitja Lainscak, Stefan Agewall, Thomas A Schmidt

Eur Heart J Cardiovasc Pharmacother· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Alexander Niessner, Juan Tamargo, Lorenz Koller, Christoph H Saely, Thomas Andersen Schmidt

Eur Heart J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Market licensing of type 2 diabetes medicinal products based on patient-relevant hard outcomes: is there hope?
Thomas A Schmidt

Eur Heart J Cardiovasc Pharmacother· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalisation in an emergency department short-stay unit compared to an internal medicine department is associated with fewer complications in older patients - an observational study.
Camilla Strøm, Talie Khadem Mollerup, Laurits Schou Kromberg, Lars Simon Rasmussen, Thomas Andersen Schmidt

Scand J Trauma Resusc Emerg Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colles' fractures and osteoporosis--A new role for the Emergency Department.
Christopher Jantzen, Lars K Cieslak, Ayob F Barzanji, Per B Johansen, Søren W Rasmussen, Thomas A Schmidt

Injury· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency team calls for critically ill non-trauma patients in the emergency department: an observational study.
Søren Marker Jensen, Hien Quoc Do, Søren W Rasmussen, Lars S Rasmussen, Thomas Andersen Schmidt

Scand J Trauma Resusc Emerg Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Lancet Diabetes & Endocrinology needs a more rigorous conflict of interest policy.
Thomas A Schmidt, John S Yudkin

Lancet Diabetes Endocrinol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis